Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Total Costs & Expenses Over TimeStable
Percentile Rank79
3Y CAGR+4.0%
5Y CAGR-4.8%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+4.0%/yr
vs +7.1%/yr prior
5Y CAGR
-4.8%/yr
Recent acceleration
Acceleration
-3.1pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$123.87M-0.9%
2024$125.01M+4.2%
2023$119.95M+8.9%
2022$110.16M-24.1%
2021$145.18M-8.6%
2020$158.78M+97.6%
2019$80.36M-4.1%
2018$83.81M+23.8%
2017$67.69M+28.3%
2016$52.77M-